ClinicalTrials.Veeva

Menu

Cystatin C and Uncontrolled Hypertension

A

Ankara University

Status

Completed

Conditions

Uncontrolled Hypertension

Treatments

Other: other

Study type

Observational

Funder types

Other

Identifiers

NCT02334033
AnkaraUHyper

Details and patient eligibility

About

Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.

Enrollment

903 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals who accept to participate to the survey
  • > 18 years

Exclusion criteria

  • Individuals who are not able to complete the questionnaire
  • Individuals who didn't give informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems